期刊文献+

肝细胞癌手术后辅助肝动脉化疗栓塞与单纯手术的疗效比较 被引量:9

Hepatic resection for hepatocellular carcinoma with or without postoperative adjuvant transarterial chemoembolization: a comparative study
原文传递
导出
摘要 目的探讨肝细胞癌(HCC)根治性切除术后辅助肝动脉化疗栓塞(TACE)对患者生存期的影响。方法收集2007年3月至2010年3月229例肝细胞癌患者手术资料。其中手术后辅助TACE治疗91例,单纯手术138例。采用倾向性得分匹配法(PSM)均衡组问协变量,获得匹配患者并对其进行生存分析。结果经PSM匹配后得到67对患者。匹配后手术+TACE组和单纯手术组中位生存期分别为32.1个月和28.3个月,1年、2年、3年生存率分别为94.0%、84.8%、75.3%和83.6%、69.9%、61.5%,两组间差异无统计学意义(P=0.062)。单因素分析结果显示,AFP水平、肿瘤大小、肿瘤数量、BCLC分期、辅助性TACE对HCC患者术后累计生存率有一定的影响(P〈0.05)。Cox回归模型分析表明AFP≥400μg/L、肿瘤直径〉5cm是影响HCC手术后累计生存率的独立危险因素(P〈0.05)。结论HCC患者手术后辅助TACE并不能显著提高患者的生存率,因此术后采用TACE须慎重。AFP≥400μg/L、肿瘤直径〉5cm是影响HCC手术后生存率的独立危险因素。 Objective To explore the efficacy of postoperative adjuvant transarterial chemoembolization (TACE) on the survival of patients after radical resection for hepatocellular carcinoma (HCC). Methods Between March 2007 and March 2010, 229 HCC patients who underwent radical resection were retrospectively studied. Patients who underwent resection alone were used as the control group ( 138 patients) while those who received post-operative adjuvant TACE was used as the interventional group. In order to balance the covariates between the groups, a matched comparison of the patients was done by selecting patients using the propensity score matching (PSM). Then, the efficacy of adjuvant TACE upon survival was evaluated. Results After PSM, we obtained 67 pairs of patients. The survival time for the interventional and the control groups were 32.1 months and 28.3 months respectively. The survival rates at year 1, 2, 3 post-resection were 94.0%, 84.8% and 75.3% in the interventional group versus 83.6%, 69.9% and 61.5% in the control group respectively. There were no significant differences between the two groups (P = 0. 062). Univariate analysis showed the serum level of AFP, tumor size, number of tumor, BCLC stage, and adjuvant TACE significantly affected the survival of HCC patients who received radical resection (P 〈 0. 05). Cox model suggested that AFP≥400μg/L and tumor diameter 〉 5 cm were independent risk factors of survival for HCC patients who received radical resection (P 〈 0.05). Conclusion Postoperative adjuvant TACE had no positive effect on survival, and AFP level ≥400μg/L and tumor size 〉 5 cm were independent risk factors of survival of HCC patients who received radical resection.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第5期333-337,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81260331) 国家科技重大专项课题(2012ZX10002010001009)
关键词 肝细胞癌 生存率 肝动脉化疗栓塞 倾向性得分匹配法 Hepatocellular carcinoma Survival rate Transarterial chemoembolization Propensity score matching
  • 相关文献

参考文献3

二级参考文献29

  • 1Ji-Dong Gao, Yong-Fu Shao, Yang Xu, Li-Hua Ming, Zhi-Yuan Wu, Guo-Ting Liu, Xiao-Hong Wang, Wen-Hong Gao, Yun-Tian Sun, Xiao-Li Feng, Li-Ming Liang, Yun-Hui Zhang and Zong-Tang Sun Beijing, China Department of General Surgery, Cancer Hospital,National Laboratory of Molecular On- cology, Cancer Institute ,Department of Pathology, Cancer Hospital ,and Central Laboratory, Cancer Institute , Chinese Academy of Medical Sciences, Peking Union Medical College, Bei- jing 100021 , China.Tight association of hepatocellular carcinoma with HBV infection in North China[J].Hepatobiliary & Pancreatic Diseases International,2005,4(1):46-49. 被引量:7
  • 2Austin PC.A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.Stat Med,2008,27:2037-2049.
  • 3Austin PC,Grootendorst P,Anderson GM.A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects:a Monte Carlo study.Stat Med,2007,26:734-753.
  • 4Rosenbaum PR,Rubin DB.The central role of the propensity score in observational studies for causal effects.Biometrika,1983,70:41-55.
  • 5Katherine HH,Thomas AL.Propensity score modeling strategies for the causal analysis of observational data.Biostatistics,2002,2:179-193.
  • 6Austin PC,Mamdanil MM.A comparison of propensity score methods:a case-study estimating the effectiveness of post-AMI statin use.Stat Med,2006,25:2084-2106.
  • 7Ekundayo OJ,Adamopoulos C,Ahmed MI,et al.Oral potassium supplement use and outcomes in chronic heart failure:a propensity-matched study.Int J Cardiol,2009.
  • 8D'Agostino RB.Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.Stat Med,1998,17:2265-2281.
  • 9Brookhart MA,Schneeweiss S,Rothman KJ,et al.Variable selection for propensity score models.Prac Epidemiol,2006,163:1149-1156.
  • 10Perkins SM,Tu W,Underhill MG,et al.The use of propensity scores in pharmacoepidemioiogic research.Pharmacoepidemiol Drug Safety,2000,9:93-101.

共引文献130

同被引文献91

引证文献9

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部